StockData
Protagonist Therapeutics, Inc logo

Protagonist Therapeutics, Inc (PTGX) stock

PTGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/30199% above fair value
$127.16+2.49 (+2.00%)

Close on Nov 18, 2026Market cap $8.23BP/E 123.5Yield –

Protagonist Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Protagonist Therapeutics's price to sales ratio was 30.9× on Nov 11, 2026, against 26.9× a year earlier. Over the last 5 years it ranged from 5.2× to 143.3×, with a median of 24.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202630.9×+4.9
2025Dec 31, 202526.1×+19.0
2024Dec 31, 20247.1×−34.9
2023Apr 28, 202342.0×+26.7
2022Dec 30, 202215.3×−51.6
2021Dec 31, 202166.8×+55.0
2019Jul 31, 201911.9×+7.8
2018Dec 31, 20184.1×–

More Protagonist Therapeutics figures

See a number that looks wrong?